The U.S. Drug Enforcement Agency is investigating mental health startup Done for its prescription of controlled substances, according to a news story.
The Wall Street Journal first reported on the investigation.
According to the report, the DEA’s Diversion Control Division is leading the investigation into Done and fellow online mental health startup Cerebral about their prescription of Adderall and other controlled substances.
A…